DCF Advisers’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-19,417
| Closed | -$101K | – | 95 |
|
|
2024
Q3 | $101K | Sell |
19,417
-230,583
| -92% | -$1.2M | 0.04% | 77 |
|
|
2024
Q2 | $643K | Sell |
250,000
-13,372
| -5% | -$34.4K | 0.33% | 57 |
|
|
2024
Q1 | $1.3M | Buy |
263,372
+6,500
| +3% | +$32K | 0.64% | 34 |
|
|
2023
Q4 | $2.26M | Buy |
256,872
+230,372
| +869% | +$2.02M | 1.23% | 20 |
|
|
2023
Q3 | $304K | Buy |
+26,500
| New | +$304K | 0.17% | 62 |
|
|
2022
Q3 | – | Sell |
-12,000
| Closed | -$166K | – | 78 |
|
|
2022
Q2 | $166K | Buy |
+12,000
| New | +$166K | 0.1% | 56 |
|